An Open Study With OXN to Evaluate the Patient Preference for Pain Treatment With Respect to Quality of Life After WHO Stap I or Step II Analgesics for Patients With Moderate to Severe Non-malignant Pain

Trial Profile

An Open Study With OXN to Evaluate the Patient Preference for Pain Treatment With Respect to Quality of Life After WHO Stap I or Step II Analgesics for Patients With Moderate to Severe Non-malignant Pain

Completed
Phase of Trial: Phase III

Latest Information Update: 23 May 2014

At a glance

  • Drugs Oxycodone/naloxone (Primary)
  • Indications Pain
  • Focus Therapeutic Use
  • Acronyms PREFER
  • Sponsors Mundipharma CVA
  • Most Recent Events

    • 04 Jul 2012 Planned number of patients changed from 180 to 215 as reported by European Clinical Trials Database (EudraCT2008-001026-14).
    • 21 Jul 2010 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health record NCT01167699).
    • 21 Jul 2010 Actual initiation date (Jun 2009) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top